Patent · US Active

Method for the diagnosis of the presence of an ovarian cancer

US9200262B2 · kind B2 · utility

0Cited by
2References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 9, 2011
Grant dateDec 1, 2015
Priority date
Expiry dateAug 4, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/975
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides an isolated antigen polypeptide that can be expressed in a subject with ovarian cancer. Also provided is the diagnosis of ovarian cancer by using the antigen polypeptide of the invention and the prevention and/or treatment of ovarian cancer by suppressing the gene of the antigen polypeptide of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.